Global Protein A Resin Market 2023
Description
Global Protein A Resin Market 2023
The global protein a resin market was valued at USD 833 million in 2022 to USD 1,586 million by 2029, progressing at a CAGR of 9.6% from 2023 to 2029, according to the latest market study results.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, type, application, end user, and region. The global market data on protein a resin can be segmented by product: agarose-based protein A, glass and silica-based protein A, organic polymer-based protein A. According to the research, the agarose-based protein A segment had the largest share in the global protein a resin market. Protein a resin market is further segmented by type: natural protein A, recombinant protein A. In 2022, the natural protein A segment made up the largest share of revenue generated by the protein a resin market. Based on application, the protein a resin market is segmented into: antibody purification, immunoprecipitation. Among these, the antibody purification segment was accounted for the highest revenue generator in 2022. On the basis of end user, the protein a resin market also can be divided into: pharmaceutical and biopharmaceutical companies, research institutes, others. The pharmaceutical and biopharmaceutical companies segment captured the largest share of the market in 2022. Protein a resin market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
The global protein a resin market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Avantor Inc., Bio-Rad Laboratories Inc., GE Healthcare, Genscript Biotech Corp., Kaneka Corporation, Merck & Co., Novasep Holding SAS, PerkinElmer Inc., Purolite Corporation, Repligen Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
The global protein a resin market was valued at USD 833 million in 2022 to USD 1,586 million by 2029, progressing at a CAGR of 9.6% from 2023 to 2029, according to the latest market study results.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, type, application, end user, and region. The global market data on protein a resin can be segmented by product: agarose-based protein A, glass and silica-based protein A, organic polymer-based protein A. According to the research, the agarose-based protein A segment had the largest share in the global protein a resin market. Protein a resin market is further segmented by type: natural protein A, recombinant protein A. In 2022, the natural protein A segment made up the largest share of revenue generated by the protein a resin market. Based on application, the protein a resin market is segmented into: antibody purification, immunoprecipitation. Among these, the antibody purification segment was accounted for the highest revenue generator in 2022. On the basis of end user, the protein a resin market also can be divided into: pharmaceutical and biopharmaceutical companies, research institutes, others. The pharmaceutical and biopharmaceutical companies segment captured the largest share of the market in 2022. Protein a resin market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
The global protein a resin market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Avantor Inc., Bio-Rad Laboratories Inc., GE Healthcare, Genscript Biotech Corp., Kaneka Corporation, Merck & Co., Novasep Holding SAS, PerkinElmer Inc., Purolite Corporation, Repligen Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global Protein A Resin Market
- Identify segments/areas to invest in over the forecast period in the Global Protein A Resin Market
- Understand the competitive environment, the market’s leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Table of Contents
45 Pages
- Part 1. Summary
- Part 2. Introduction
- Study period
- Geographical scope
- Market segmentation
- Part 3. Protein a resin market overview
- Part 4. Market breakdown by product
- Agarose-based protein A
- Glass and silica-based protein A
- Organic polymer-based protein A
- Part 5. Market breakdown by type
- Natural protein A
- Recombinant protein A
- Part 6. Market breakdown by application
- Antibody purification
- Immunoprecipitation
- Part 7. Market breakdown by end user
- Pharmaceutical and biopharmaceutical companies
- Research institutes
- Others
- Part 8. Market breakdown by region
- North America
- Europe
- Asia-Pacific
- MEA (Middle East and Africa)
- Latin America
- Part 9. Key companies
- Agilent Technologies Inc.
- Avantor, Inc.
- Bio-Rad Laboratories Inc.
- GE Healthcare
- Genscript Biotech Corp.
- Kaneka Corporation
- Merck & Co.
- Novasep Holding SAS
- PerkinElmer Inc.
- Purolite Corporation
- Repligen Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Tosoh Corporation
- Part 10. Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
